EcoDrugPlus

Ensembl ID : ENSORLG00000016513
Gene Symbol: RPL35
1 Cross references
275 Possible Orthologues:

Ensembl ID : ENSORLG00000030213
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSORLG00000030335
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSORLG00000001211
Gene Symbol: -
Cross references: -
24 Possible Orthologues:

Ensembl ID : ENSORLG00000007464
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSORLG00000014338
Gene Symbol: -
Cross references: -
104 Possible Orthologues:

Ensembl ID : ENSORLG00000015799
Gene Symbol: -
Cross references: -
13 Possible Orthologues:

Ensembl ID : ENSORLG00000016024
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSORLG00000003475
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSORLG00000017305
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSORLG00000030075
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSORLG00000017457
Gene Symbol: -
Cross references: -
53 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).